Evaluating how cancer treatments are processed in the body before clinical use
Contract Orientation and Kickoff Meeting in support of IDIQ - Preclinical Pharmacokinetic and Pharmacology Evaluations of Agents Being Developed for Cancer Patients (R&D services)
This study is looking at how new cancer treatments work in the body to make sure they are safe and effective for patients like you in future trials, with the goal of finding better therapies for cancer.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-10502683 on NIH RePORTER |
What this research studies
This research focuses on the preclinical evaluation of how potential cancer treatments are absorbed, distributed, metabolized, and excreted in the body. It involves detailed pharmacokinetic and pharmacology assessments to understand the effectiveness and safety of new agents being developed for cancer patients. The approach includes rigorous testing and analysis to ensure that these treatments can be safely administered to patients in future clinical trials. Patients may benefit from this research as it aims to improve the development of more effective cancer therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with cancer who may benefit from new treatment options.
Not a fit: Patients who are not currently diagnosed with cancer or those who are not eligible for new treatment trials may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of safer and more effective cancer treatments.
How similar studies have performed: Similar research in pharmacokinetics and pharmacology has shown success in improving cancer treatment development, indicating a promising approach.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.